Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Global University Venturing

10 spinouts to watch: December 2022

Enzymes to infinitely recycle plastic, a way to make green ammonia and an app to detect early Alzheimer's are among this month's noteworthy technologies.


Dec 12, 2022

Russell is the new PraxisAuril CEO

David Russell, an executive-in-residence at Oxford’s Saïd Business School, has been appointed chief executive of PraxisAuril, following in the footsteps of Maxine Ficarra.

Dec 8, 2022

100 sign Innovate Cambridge charter

Cambridge Enterprise, Cambridge Innovation Capital and University of Cambridge are joined by 100 signatories like AstraZeneca and Microsoft for the Innovate Cambridge initiative.

Dec 8, 2022

BioBetter offers climate security one bite at a time

BioBetter’s technology utilises tobacco plants to provide a climate-friendly response to the meat production industry.

Dec 5, 2022

10 spinouts to watch: November 2022

Cures for HIV and blurred vision and using cosmic rays to monitor nuclear waste drums are on our list of recent promising university spinouts.

Nov 21, 2022

SETsquared reaches for Reid

Marty Reid, director of SETsquared Bristol and Engine Shed, will step up as interim executive director of SETsquared next month.

Nov 15, 2022

WPI wins over Wang

Grace Wang is leaving Ohio State University after two years to become president of Worcester Polytechnic Institute.

Nov 7, 2022

RIVF chooses Connallon

Michael Connallon Jr is the new chairman of the Rowan Innovation Venture Fund, the freshly topped up venture capital arm of Rowan University.

Nov 2, 2022

Tartu makes Maasik head of EIK

Mart Maasik is the head of University of Tartu’s Entrepreneurship and Innovation Centre, but will also remain head of UniTartu Ventures.

Nov 1, 2022

CasInvent Pharma goes for cancer hat-trick

CasInvent Pharma’s approach is aimed at three forms of cancer rather than just one, with leukaemia, lymphoma and solid tumours all in its sights.

Nov 1, 2022

Spinouts are thriving despite slump

Spinouts have defied the slump in the rest of the market, with deal numbers up 10% from last year. The average size of seed and series B rounds has actually increased.

Oct 27, 2022
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here